Search Results - Tambralli, A.

Search alternatives:

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    NETs in APS: Current Knowledge and Future Perspectives by Tambralli, Ajay, Gockman, Kelsey, Knight, Jason S.

    Published in Current rheumatology reports (26-08-2020)
    “…Purpose of Review Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease that is primarily treated with anticoagulation. Better understanding the…”
    Get full text
    Journal Article
  2. 2

    Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases by Tambralli, Ajay, Beukelman, Timothy, Cron, Randy Quentin, Stoll, Matthew Laurence

    Published in Journal of rheumatology (01-03-2015)
    “…Rituximab (RTX) has been used to treat many pediatric autoimmune conditions. We investigated the safety and efficacy of RTX in a variety of pediatric…”
    Get full text
    Journal Article
  3. 3

    Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffold by Blakeney, Bryan A, Tambralli, Ajay, Anderson, Joel M, Andukuri, Adinarayana, Lim, Dong-Jin, Dean, Derrick R, Jun, Ho-Wook

    Published in Biomaterials (01-02-2011)
    “…Abstract A limiting factor of traditional electrospinning is that the electrospun scaffolds consist entirely of tightly packed nanofiber layers that only…”
    Get full text
    Journal Article
  4. 4

    Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series by Madison, Jacqueline A, Gockman, Kelsey, Hoy, Claire, Tambralli, Ajay, Zuo, Yu, Knight, Jason S

    Published in Pediatric rheumatology online journal (23-02-2022)
    “…Pediatric antiphospholipid syndrome (APS) is a thromboinflammatory disease characterized by the presence of circulating antiphospholipid antibodies and either…”
    Get full text
    Journal Article
  5. 5

    High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis by TAMBRALLI, Ajay, BEUKELMAN, Timothy, WEISER, Peter, ATKINSON, Thomas Prescott, CRON, Randy Quentin, STOLL, Matthew Laurence

    Published in Journal of rheumatology (01-10-2013)
    “…To review our experiences with high-dose infliximab (IFX) to treat juvenile idiopathic arthritis (JIA). We routinely use high doses of IFX (10-20 mg/kg) in…”
    Get full text
    Journal Article
  6. 6

    Osteogenic Differentiation of Human Mesenchymal Stem Cells Directed by Extracellular Matrix-Mimicking Ligands in a Biomimetic Self-Assembled Peptide Amphiphile Nanomatrix by Anderson, Joel M, Kushwaha, Meenakshi, Tambralli, Ajay, Bellis, Susan L, Camata, Renato P, Jun, Ho-Wook

    Published in Biomacromolecules (12-10-2009)
    “…This study investigated the ability of nanoscale, biomimetic peptide amphiphile (PA) scaffolds inscribed with specific cellular adhesive ligands to direct the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets by Cecchi, Irene, Radin, Massimo, Rodríguez-Carrio, Javier, Tambralli, Ajay, Knight, Jason S, Sciascia, Savino

    Published in Expert review of clinical immunology (03-04-2021)
    “…Antiphospholipid Syndrome (APS) is a systemic autoimmune disease with a complex multifactorial pathogenesis, combining genetic background, traditional…”
    Get more information
    Journal Article
  11. 11

    Predictors and Interrelationship of Patient‐Reported Outcomes in Antiphospholipid Syndrome: A Cross‐Sectional Study by Weiner, Julia K., Smith, Tristin, Hoy, Claire K., Sarosh, Cyrus, Madison, Jacqueline A., Ambati, Amala, Tambralli, Ajay, Peters, Noah, Packel, Corinne, Gockman, Kelsey, Zuo, Yu, Briceño, Emily M., Nagaraja, Vivek, Knight, Jason S.

    Published in ACR open rheumatology (01-01-2023)
    “…Objective This study assessed patient‐reported outcomes (PROs) in individuals with persistently positive antiphospholipid antibodies (aPL) to better understand…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants by Andukuri, Adinarayana, Kushwaha, Meenakshi, Tambralli, Ajay, Anderson, Joel M., Dean, Derrick R., Berry, Joel L., Sohn, Young Doug, Yoon, Young-Sup, Brott, Brigitta C., Jun, Ho-Wook

    Published in Acta biomaterialia (01-01-2011)
    “…Current cardiovascular therapies are limited by the loss of endothelium, restenosis and thrombosis. The goal of this study was to develop a biomimetic hybrid…”
    Get full text
    Journal Article
  14. 14

    A hybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibers by Tambralli, Ajay, Blakeney, Bryan, Anderson, Joel, Kushwaha, Meenakshi, Andukuri, Adinarayana, Dean, Derrick, Jun, Ho-Wook

    Published in Biofabrication (01-06-2009)
    “…Nanofibrous electrospun poly (epsilon-caprolactone) (ePCL) scaffolds have inherent structural advantages, but lack of bioactivity has limited their usefulness…”
    Get more information
    Journal Article
  15. 15

    A bio-inspired hybrid nanosack for graft vascularization at the omentum by Hwang, Patrick T.J., Lim, Dong-Jin, Fee, Timothy, Alexander, Grant C., Tambralli, Ajay, Andukuri, Adinarayana, Tian, Liqun, Cui, Wanxing, Berry, Joel, Gilbert, Shawn R., Jun, Ho-Wook

    Published in Acta biomaterialia (01-09-2016)
    “…[Display omitted] For three-dimensional tissue engineering scaffolds, the major challenges of hydrogels are poor mechanical integrity and difficulty in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A Novel Approach for Design, Implementation and Construction of Low Density Parity Check (LDPC) Memory by Harshitha, B., Karthik, M., Tambralli, Vinayak

    “…Memory is an important part of any digital circuit in which data is stored and retrieved. Technology scaling, lower operating voltages and high integration…”
    Get full text
    Conference Proceeding